Implant failure caused by non-union of bisphosphonate-associated subtrochanteric femur fracture.
Bisphosphonate use has been identified as a contributory factor in atypical subtrochanteric fracture of the femur. These fractures are commonly treated with an intramedullary device. We present a case of implant failure of an intrameduallary device caused by non-union of an atypical subtrochanteric fracture.
Department of Trauma & Orthopaedics, Connolly Hospital, Dublin, Ireland.
Barry James
BJ
O'Neill
Sven
S
O'hEireamhoin
David I
DI
Morrissey
Peter
P
Keogh
D019386:Alendronate / Q000009:adverse effects*; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D020878:Device Removal; D005260:Female; D005264:Femoral Fractures / Q000000981:diagnostic imaging / Q000601:surgery*; D005594:Fracture Fixation, Intramedullary; D006620:Hip Fractures / Q000000981:diagnostic imaging / Q000601:surgery*; D006801:Humans; D008875:Middle Aged; D011475:Prosthesis Failure / Q000209:etiology*; D011859:Radiography; D012086:Reoperation
D050071:Bone Density Conservation Agents; D019386:Alendronate